The purpose of this protocol is to retrospectively study the influence of age at start of
growth hormone (GH) treatment on height gain in children born small for gestational age
- SGA children.
- Treated with GH at least 36 months.
- Patients treated with GH for other indications (not SGA).
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
Pfizer Clinical Trials Contact Center
call now email
Contact a representative by phone, email, or visiting the study website. Please see the references below: